Position in PFE
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$483,887
-$77,291 QoQ
Shares Held
20,095
+0.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,775
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Stonebridge Capital Advisors LLC holds $79,452,749 across 7 Drug Manufacturers - General names. PFE ranks #6 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
86,589 | $21,991,008 | |
| 2 | MRK |
Merck & Co., Inc.
|
148,656 | $19,102,296 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
112,875 | $14,260,627 | |
| 4 | LLY |
ELI LILLY & Co
|
11,574 | $13,882,203 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
162,082 | $9,339,164 | |
| 6 | PFE |
Pfizer Inc
This page
|
20,095 | $483,887 | |
| 7 | ABBV |
AbbVie Inc.
|
1,564 | $393,564 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $483,887 | 20,095 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $561,178 | 19,985 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $507,810 | 20,394 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $521,269 | 20,458 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $565,543 | 23,331 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $613,025 | 24,192 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $585,384 | 22,065 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $770,585 | 26,627 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $809,825 | 28,943 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $737,761 | 26,586 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $566,155 | 19,665 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $721,679 | 21,757 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $828,894 | 22,598 | Shares | Sole | 2023-08-23 | |
| 2023-03-31 | $885,360 | 21,700 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,098,585 | 21,440 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $942,634 | 21,541 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,113,665 | 21,241 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,146,187 | 22,140 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $1,474,360 | 24,968 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,018,390 | 23,678 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $938,273 | 23,960 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $868,070 | 23,960 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $918,961 | 24,965 | Shares | Sole | 2021-03-05 | |
| 2020-09-30 | $875,697 | 23,861 | Shares | Sole | 2020-11-18 | |
| 2020-06-30 | $760,275 | 23,250 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $776,047 | 23,776 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||